DRKS00027887已完成未知
Robot-assisted gait training in patients with neurological disorders: a comparative multiple case study - RAGT-Neuro-1
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- All
入选标准
- •Age 18-99 years, male, female and diverse gender, any ethnicity, first-ever ischemic or hemorrhagic stroke, multiple sclerosis (MS), Parkinson’s Disease (PD), a spastic para- or tetraplegia caused by any type of spinal cord lesion, mild to medium grade hereditary ataxia, acute or chronic inflammatory demyelinating polyneuropathy (e.g., GBS, CIDP) or a motoneuron disease (e.g., ALS). All patients must be in a clinically stable phase of their disease, patients with subacute, severe stroke who are non-ambulatory are eligible if they can be verticalised for at least 1 hour twice a day. Further inclusion criteria will be impairment in walking according to the neurological exam assessed by a neurologist and Functional Ambulation Categories (FAC) of 0-4, intact cognitive function as defined by a score of =24/30 points on the Mini Mental State Examination (MMSE) (Folstein et al., 1975) and German speaking verbally and written language.
排除标准
- •Concomitant disease (such as malignant disease, other severe neurological, orthopaedic or psychiatric diseases, cardiac contraindications), acute, pronounced pain symptoms despite conventional pain therapy, joint contractures, joint arthrodesis or severe spasticity (stiff/immobile joint) in the area of the lower extremity, extremely disproportionate growth of the legs and/or spinal column, body weight of less than 15 kg or more than 180 kg, body height of less than 100 cm or more than 200 cm, insufficient compliance e.g., patients with a serious mental illness or severe neurosis, significant reduction in bone density (osteopenia or osteoporosis), increased risk of bone fracture, osseous or joint instability (non-consolidated fractures, osteogenesis imperfecta, unstable spinal column, pseudoarthrosis, hip, knee or ankle joint instability), cardiac contraindications, severe vascular diseases of the lower limbs, high-grade ataxia, skin lesions in areas which get in contact with the device or the harness system (decubitus); infections, skin ulcers, late effects of previous injuries, especially of the lower extremity, states of health preventing active rehabilitation (e.g., respiratory diseases, orthopaedic diseases, cognitive impairments restricting communication, aphasia, neuropsychological disorders, infections or inflammatory diseases, osteomyelitis), severe apraxia, severe osteoarthritis in the area of the joints of the lower extremity, risk of autonomic dysreflexia (AD) in patients with spinal cord injury (SCI) with neurological levels of TH6 or cranial, reduced compliance, uncooperative or (self)aggressive behavior, cardiac diseases, e.g., heart failure and thoracotomy, uncontrolled orthostatic hypotension or other circulatory problems, circulatory disorders of the lower limbs, recent joint injury or endoprosthetics (e.g., total endoprosthetics, knee or hip joint replacement, reconstruction of the cruciate ligament or meniscus) with contraindicated ranges of movement or load limits, consolidated fractures in the area of the lower extremity within a period of 6 months after injury, insufficiently treated epilepsy, recently occurred seizures or increased risk of seizures, mechanical ventilation, lack of head control, long-term infusions (e.g., Baclofen pump, intrathecal pumps, PEG tube …) or stimulators (e.g., pacemakers, nerve stimulators), enterostomy/ostomy, sensory impairments of the lower extremities and the torso, especially reduced sensation of pain, pregnancy as assessed by a pregnancy test in women of childbearing age before enrolment into the study, an MS relapse or other disease exacerbation for any of the included diseases during the intervention period will lead to the exclusion of a participant from the study, any changes or adjustments to medication that has an influence on the participant’s walking ability/performance will lead to the exclusion of the patient.
研究者
相似试验
已完成
不适用
Robotic support in gait training for neurological patientsStrokeNL-OMON44012niversiteit Twente50
招募中
不适用
Robot-assisted gait training for patients with hemiplegic stroke comparison of effects of conventional physical therapy: retrospective studyKCT0006583Yonsei University50
尚未招募
2 期
The study of walking after training with robotic exoskeletion in persons with incomplete spinal cord injuryCTRI/2020/10/028328International Institute of Information Technology Bengaluru
已完成
不适用
Robot-assisted walking training for patients with subacute strokeKCT0001837Wonkwang University Hospital20
已完成
不适用
Robot-assisted gait training and assessment for neurological patientsStrokeNL-OMON47656niversiteit Twente130